
OLD Category: signatures
February 26, 2019 / Blood Adv.
PD-L1 and tumor-associated macrophages in de novo DLBCL
February 26, 2019 / Int J Cancer.
Rogaratinib: A potent and selective pan-FGFR inhibitor with broad antitumor activity in FGFR-overexpressing preclinical cancer models
February 26, 2019 / Clin Cancer Res
Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials
February 25, 2019 / Nat Med
A Single Dose of Neoadjuvant PD-1 Blockade Predicts Clinical Outcomes in Resectable Melanoma
February 23, 2019 / Ann Oncol.
Context matters—consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials
February 22, 2019 / FASEB J
Genome-wide effect of pulmonary airway epithelial cell–specific Bmal1 deletion
February 22, 2019 / J Pathol
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
February 22, 2019 / Breast Cancer Res Treat.
Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach
February 22, 2019 / Front Cell Neurosci.
Microglia-Derived Microvesicles Affect Microglia Phenotype in Glioma
February 20, 2019 / Sci Rep